Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers -- role of estrogen receptor and HER2 reactivation
-
* Corresponding author: Rachel Schiff rschiff@bcm.edu
Breast Cancer Research 2011, 13:R121 doi:10.1186/bcr3067
No comments have yet been made on this article.